论文信息 - Treatment of recurrent erythema nodosum leprosum with infliximab. - 字舞流文

Treatment of recurrent erythema nodosum leprosum with infliximab.

To the Editor: A 52-year-old woman with multibacillary (borderline lepromatous) leprosy, who had been treated intermittently with dapsone since 1965, presented to our department in 1996 with active...

W. F. M. Goldschmidt | W. Faber | A. J. Jensema

[1] Khusru Asadullah,et al. Biology of tumor necrosis factor‐α– implications for psoriasis , 2004, Experimental dermatology.

[2] G. Kaplan,et al. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. , 1993, The Journal of infectious diseases.

[3] E. Sarno,et al. In vitro tumor necrosis factor production by mononuclear cells from lepromatous leprosy patients and from patients with erythema nodosum leprosum. , 1993, Clinical immunology and immunopathology.

[4] P. Brennan,et al. Tumor necrosis factor production in patients with leprosy , 1992, Infection and immunity.

[5] G. Grau,et al. Serum levels of tumour necrosis factor‐alpha and interleuk in‐1 β during leprosy reactional srates , 1991 .

[6] G. Grau,et al. Serum levels of tumour necrosis factor-alpha and interleukin-1 beta during leprosy reactional states. , 1991, Clinical and experimental immunology.